An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Cumulative incidence of treatment-related grade 2 or higher rectal bleeding.
2 years after completion of radiation therapy
Randal H. Henderson, MD, MBA
University of Florida Proton Therapy Institute
United States: Institutional Review Board
|University of Florida Proton Therapy Institute||Jacksonville, Florida 32206|